| human | Q5 |
| P106 | occupation | researcher | Q1650915 |
| Q46513261 | Adipocyte-specific overexpression of FOXC2 prevents diet-induced increases in intramuscular fatty acyl CoA and insulin resistance |
| Q35830162 | Aging-associated reductions in AMP-activated protein kinase activity and mitochondrial biogenesis |
| Q36082167 | Continuous fat oxidation in acetyl-CoA carboxylase 2 knockout mice increases total energy expenditure, reduces fat mass, and improves insulin sensitivity |
| Q33642230 | Hepatic overexpression of glycerol-sn-3-phosphate acyltransferase 1 in rats causes insulin resistance |
| Q28586493 | Inactivation of fatty acid transport protein 1 prevents fat-induced insulin resistance in skeletal muscle |
| Q28571421 | Inhibition of protein kinase Cepsilon prevents hepatic insulin resistance in nonalcoholic fatty liver disease |
| Q42462295 | Mechanism of hepatic insulin resistance in non-alcoholic fatty liver disease. |
| Q28253498 | Mitochondrial dysfunction due to long-chain Acyl-CoA dehydrogenase deficiency causes hepatic steatosis and hepatic insulin resistance |
| Q39989111 | PKC-theta knockout mice are protected from fat-induced insulin resistance |
| Q37006469 | Paradoxical effects of increased expression of PGC-1alpha on muscle mitochondrial function and insulin-stimulated muscle glucose metabolism |
| Q28593025 | Prevention of hepatic steatosis and hepatic insulin resistance in mitochondrial acyl-CoA:glycerol-sn-3-phosphate acyltransferase 1 knockout mice |
| Q41849375 | Resistance to high-fat diet-induced obesity and insulin resistance in mice with very long-chain acyl-CoA dehydrogenase deficiency |
| Q42033681 | Reversal of diet-induced hepatic steatosis and hepatic insulin resistance by antisense oligonucleotide inhibitors of acetyl-CoA carboxylases 1 and 2. |
| Q28583146 | Suppression of diacylglycerol acyltransferase-2 (DGAT2), but not DGAT1, with antisense oligonucleotides reverses diet-induced hepatic steatosis and insulin resistance |
Search more.